Virios Therapeutics Stock Quote VIRI - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.22

Bid

0.22

Ask

0.23

Volume

811,509

0.2161 Day's Range 0.2397

0.1557 52 Week Range 2.18

Market Cap

4.237M

Previous Close

0.2318

Open

0.2312

Last Trade

200

0.22

(formt)

Last Trade Time

Financial Volume

$ 182,969

VWAP

0.225467

Average Volume (3m)

1,729,058

Shares Outstanding

19,257,937

Dividend Yield

PE Ratio

-0.80

Earnings Per Share (EPS)

-0.28

Revenue

Net Profit

-5.3M

Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people wh... Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people who are suffering from fibromyalgia. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.virios.com

Headquarters

Dover, Delaware, USA

Founded

1970

Virios Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VIRI. The last closing price for Virios Therapeutics was $0.23. Over the last year, Virios Therapeutics shares have traded in a share price range of $ 0.1557 to $ 2.18.

Virios Therapeutics currently has 19,257,937 shares outstanding. The market capitalization of Virios Therapeutics is $4.46 million. Virios Therapeutics has a price to earnings ratio (PE ratio) of -0.80.

Virios Therapeutics Announces Completion of Enrollment in IMC-2 Phase 2 Long-COVID Study Being Conducted by Bateman Horne Center

- Virios projects releasing top line results from this groundbreaking Proof of Concept study in October 2024 - - Published data indicates increased Epstein-Barr herpes virus in Long-COVID...

Form 8-K - Current report

Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study

ATLANTA, May 22, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel...

Form 424B4 - Prospectus [Rule 424(b)(4)]

Form 8-K - Current report

Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study

ATLANTA, May 19, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel...

Virios Therapeutics Announces Proposed Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study

ATLANTA, May 17, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel...

Form 424B4 - Prospectus [Rule 424(b)(4)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.04	-15.3846153846	0.26	0.2733	0.2161	1369727	0.23940717	CS
4	0.011	5.26315789474	0.209	0.3329	0.209	1876913	0.25494713	CS
12	-0.2059	-48.3446818502	0.4259	0.4609	0.1557	1729058	0.23696053	CS
26	-0.2149	-49.4136583123	0.4349	0.6288	0.1557	935739	0.26924829	CS
52	-1.95	-89.8617511521	2.17	2.18	0.1557	691111	0.48080539	CS
156	-6.0232	-96.4761660687	6.2432	9.1109	0.1557	611033	0.80071809	CS
260	-13.54	-98.4011627907	13.76	14.39	0.1557	549848	1.31296624	CS

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	259.77k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.45M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M

Symbol

Price

Vol.